3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
10
Kidney Neoplasms
2
Carcinoma, Renal Cell
2
Ovarian Neoplasms
1
Inflammation
1
Endometriosis
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Advanced Renal Cell Carcinoma (RCC)
1
Interventions
palbociclib
1
Tea
1
Sufentanil
1
Rivaroxaban
1
Morphine
1
Atorvastatin
1
Analgesia, Patient-Controlled
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Inflammation
×
Atorvastatin
×
Genitourinary
×
Clear all
NCT01821404
2018-05-07
ESTO1
Tampere University Hospital
Phase 2
Completed
160 enrolled